Broncus Holding (HKSE:02216) Price-to-Operating-Cash-Flow : (As of Jun. 04, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Broncus Holding Price-to-Operating-Cash-Flow?

As of today (2025-06-04), Broncus Holding's share price is HK$2.07. Broncus Holding's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.16. Hence, Broncus Holding's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Broncus Holding's Price-to-Operating-Cash-Flow or its related term are showing as below:

HKSE:02216's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 19.095
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Broncus Holding's Cash Flow from Operations per share for the six months ended in Dec. 2024 was HK$-0.02. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.16.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 42.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 1.90% per year.

During the past 6 years, Broncus Holding's highest 3-Year average Operating Cash Flow per Share Growth Rate was 42.20% per year. The lowest was -28.10% per year. And the median was -22.00% per year.

Broncus Holding Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Broncus Holding's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Broncus Holding Price-to-Operating-Cash-Flow Chart

Broncus Holding Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Broncus Holding Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial						-	-	-	-	-

Competitive Comparison of Broncus Holding's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Broncus Holding's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Broncus Holding's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Broncus Holding's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Broncus Holding's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Broncus Holding Price-to-Operating-Cash-Flow Calculation

Broncus Holding's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	2.07	/	-0.16
	=

Broncus Holding's Share Price of today is HK$2.07.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Broncus Holding's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0.16.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Broncus Holding Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Broncus Holding's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Broncus Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Broncus Holding Corp (HKSE:02216) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 88 Jiangling Road, Xixing Street, Room 801, 8th Floor, Building 8, Binjiang District, Hangzhou, CHN

Website

https://www.broncus.com

Broncus Holding Corp is focused on provision of interventional treatment of Chronic Obstructive Pulmonary Disease and lung cancer. It engages in the field of Interventional Pulmonology, providing solutions for lung diseases in China and globally. Its products portfolio includes the InterVapor Thermal Vapor Treatment System the only implantable medical device to treat COPD; BroncAblate Radiofrequency Ablation System the transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation Radiofrequency Ablation System the self-developed targeted radiofrequency ablation system in China to reduce the risk of acute exacerbation of COPD.

Executives

Computershare Hong Kong Trustees Limited	2301 Trustee
Zi Zhenjun
Xu Hong	2101 Beneficial owner
Xin Nuo Tong Investment Limited	2201 Interest of corporation controlled by you
Qiming Corporate Gp Iv, Ltd.	2201 Interest of corporation controlled by you
Qiming Venture Partners Iv, L.p.	2101 Beneficial owner
Qiming Gp Iv, L.p.	2201 Interest of corporation controlled by you
Dinova Capital Limited
Dinova Venture Partners Gp Iii, L.p.
Broncus Biomedical Limited
Dinova Healthcare Gamma Fund (usd) L.p.
Qm12 Limited	2101 Beneficial owner
Dinova Healthcare (hong Kong) Co., Limited
Lake Bleu Capital (hong Kong) Limited	2102 Investment manager
Hang Zhou De Nuo Shang Wu Zi Xun Zi Xun You Xian Gong Si

Broncus Holding Headlines

No Headlines